Rationale: Compared to Caucasians, African Americans are less likely to become registered organ donors. In addition, although first-person consent laws have been passed in 48 states, hospitals remain reluctant to harvest organs without the consent of the registered donor's family. Epidemiologic studies on African Americans have focused on the willingness to donate organs. Little research has been done on the positive decision-making process of becoming a registered organ donor. Objectives: The goal of this project is to identify facilitators associated with becoming a registered organ donor and providing familial notification. We hypothesize that positive outcome expectations (physical, social, and self-evaluative) will be associated with increased African American organ donor registration. We also hypothesize that increased perceived self-efficacy (PSE) will be associated with increased familial notification. Design and Methods: Using the Social Cognitive Theory as a guiding framework, a qualitative study involving focus groups will be performed and then validated by large-scale quantitative telephone surveys. African Americans, age 19 and older, who made a decision regarding organ donation at the Alabama Department of Motorized Vehicles within the past 3 months will be stratified into those who chose to become a registered organ donor and those who declined. The dependent variables for analysis will be 1) becoming a registered organ donor and 2) family notification of the decision to become a registered organ donor. Significance: The study will identify the key factors that drive African Americans to become registered organ donors and the determinants of familial notification. This data will inform future interventions to increase African American donor registration and develop mechanisms to ensure family consent, thereby reducing disparities in organ donation and improving the health outcomes of African Americans.

Public Health Relevance

African Americans who registered at the Alabama Department of Motorized Vehicles within the past three months will be stratified into those who chose to be an organ donor and those who declined. A qualitative study involving focus groups and validated by quantitative surveys will be performed to determine the factors associated with the decision of African Americans to become registered organ donors and to inform their families of their donation wishes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DK091514-02
Application #
8472490
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2012-07-01
Project End
2017-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
2
Fiscal Year
2013
Total Cost
$180,865
Indirect Cost
$13,397
Name
University of Alabama Birmingham
Department
Surgery
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Locke, Jayme E; Durand, Christine; Reed, Rhiannon D et al. (2016) Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients. Transplantation 100:141-6
Gray, Stephen H; White, Jared A; Li, Peng et al. (2016) A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. J Vasc Interv Radiol :
DuBay, Derek A; MacLennan, Paul A; Reed, Rhiannon D et al. (2016) Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes. J Am Coll Surg 223:611-620.e4
Jacob, Rojymon; Saddekni, Souheil; Dover, Laura et al. (2016) Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy. Liver Transpl 22:547-51
Haywood, Nathan; Gennaro, Kyle; Obert, John et al. (2016) Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival? J Oncol 2016:4692139
Jacob, Rojymon; Turley, Falynn; Redden, David T et al. (2015) Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm. HPB (Oxford) 17:140-9
DuBay, D A; MacLennan, P A; Reed, R D et al. (2015) The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs. Am J Transplant 15:541-6
Bryant, Mary K; Dorn, David P; Zarzour, Jessica et al. (2014) Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB (Oxford) 16:327-35
Ren, Z; Litovsky, S; Eckhoff, D E et al. (2014) Hemorrhagic shock one month following uncomplicated liver transplantation. Am J Transplant 14:1461-3
DuBay, Derek A; Redden, David T; Bryant, Mary K et al. (2014) Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria. Transplantation 97:1043-8

Showing the most recent 10 out of 17 publications